3. Methodological quality assessment results for individual trials.
Items / Trials | Atkin 1995 | Gebuhr 1992 | Leung 2003 | Van Leemput 2007 |
1. Allocation concealment | N | ? | N | N |
2. Intention‐to‐treat analysis | N | N | ? | N |
3. Assessor blinding | N | N | N | N |
4. Baseline characteristics comparability | N | N | ? | Y |
5. Participant blinding | N | N | N | N |
6. Treatment provider blinding | N | N | N | N |
7. Care programme comparability | N | N | ? | ? |
8. Inclusion and exclusion criteria | ? | Y | Y | Y |
9. Well defined outcome measures | Y | Y | Y | Y |
10. Clinically useful diagnostic tests | Y | Y | Y | ? |
11. Adequate duration of follow‐up | ? | ? | Y | ? |
Y = yes; ? = partial/unknown; N = no
* Assessments for items 9, 10 and 11 relate to the outcome of fracture non‐union.